NSAM
DNA icon

North Star Asset Management’s Ginkgo Bioworks DNA Stock Holding History

North Star Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,778
Closed -$77.3K – 326
2024
Q2 		$77.3K Buy
5,778
+3,578
+163% +$107K ﹤0.01% 305
2024
Q1 		$102K Buy
2,200
+646
+42% +$33.4K ﹤0.01% 308
2023
Q4 		$105K Buy
1,554
+200
+15% +$12.2K 0.01% 302
2023
Q3 		$98K Buy
1,354
+891
+192% +$71.2K 0.01% 289
2023
Q2 		$34.4K Sell
463
-40
-8% -$2.37K ﹤0.01% 297
2023
Q1 		$26.7K Sell
503
-412
-45% -$26.1K ﹤0.01% 301
2022
Q4 		$61.9K Buy
915
+275
+43% +$25.3K ﹤0.01% 303
2022
Q3 		$80K Sell
640
-41
-6% -$4.89K 0.01% 289
2022
Q2 		$65K Buy
+681
New +$83.1K ﹤0.01% 290

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return